ReviewAdvanced healthcare materials2026
Progressive Insights into 3D Bioprinting for Corneal Tissue Restoration.
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Type VIII collagen: advances in matrix biology and translational promise.Frontiers in bioengineering and biotechnology · 2025Pooled it
- Article
- A Novel Non-Planar Bioprinting Methodology for Enhanced Surface Fidelity of the Cornea.Bioengineering (Basel, Switzerland) · 2026Article
- The Role of Epigenetics in Corneal Fibrosis.Epigenomes · 2026Review
- Feedback-regulated 3D-printed hydrogel micropatch for integrated therapy of fungal keratitis.Theranostics · 2026Article
- A biomimetic and xeno-free platform for corneal engineering: synergy between PRGF technology and human dental pulp stem cells.Frontiers in bioengineering and biotechnology · 2026Article
- Progressive Insights into 3D Bioprinting for Corneal Tissue Restoration.Advanced healthcare materials · 2026Review
- Porcine Corneal Models as Translational Platforms for Innovative Therapies: Current Insights and Future Directions.Journal of functional biomaterials · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The complex architecture of the cornea, characterized by specifically organized collagen fibrils and distinct cellular layers, poses significant challenges for traditional tissue engineering strategies to replicate its native function. 3D Bioprinting offers a promising solution by enabling the precise, layer-by-layer fabrication of corneal tissues, closely mimicking the essential characteristics needed for vision restoration and long-term graft success. This Review critically examines the key biomechanical, optical, and structural attributes of the cornea necessary for its effective engineering and accurate 3D bioprinting. It provides a comprehensive overview of different 3D bioprinting modalities utilized for corneal tissue engineering and offers insights into potential improvements. Additionally, it details the requirements for a corneal bioink suitable for 3D bioprinting, ensuring it meets the necessary corneal functions. The Review also delves into the current challenges in 3D bioprinting of corneal tissue and proposes potential solutions to successfully replicate the complex architecture and function of the cornea. Furthermore, it explores innovative approaches such as the use of induced pluripotent stem cells, gene therapy, and cornea-on-a-chip technologies, which hold promise for advancing corneal regeneration. The Review aims to visualize the future of corneal 3D bioprinting and the potential of integrating it with other techniques. Lastly, the review discusses clinical implications, emphasizing the potential of bioprinted corneal implants to address the global donor cornea shortage and significantly improve patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.